All HIV articles
-
NewsHIV-to-HIV kidney transplants 'as safe and effective' as organs from donors without HIV
An HIV-to-HIV kidney transplant study finds that HIV-to-HIV kidney transplants is as safe and just as effective as those using organs from donors without HIV.
-
NewsNew study links historical redlining to delays in HIV treatment
A new study finds that historical race-based lending practices are still impacting health in the US today, linking these discriminatory policies to delays in effective HIV treatment within affected neighborhoods.
-
NewsResearcher targets BV, a common infection affecting women
Armed with a $2.7 million grant from the National Institutes of Health, University of Florida biomedical professor Ivana Parker, Ph.D., is targeting one of the most common – and dangerous – infections in women. Source: University of Florida/David Schlenker UF Assistant Professor Ivana Parker, Ph.D., recently ...
-
NewsTrial of rectal microbicide for HIV prevention begins in US
A clinical trial has launched to examine the safety and acceptability of a novel rectal HIV microbicide douche containing the antiretroviral drug tenofovir.
-
NewsCDC/PEPFAR awards Georgetown $27.5 million to address HIV/AIDS in Haiti
CDC and PEPFAR have awarded $27.5 million to the Center for Global Health Practice and Impact (CGHPI) at Georgetown University Medical Center to expand its ongoing work in Haiti to address HIV/AIDS.
-
NewsPart of the GBHSH community in Spain uses doxycycline to prevent STIs
Researchers have carried out the first study in Spain on the use of DoxyPEP as a preventive strategy among the gay, bisexual and other men who have sex with men (GBHSH) community in Spain.
-
NewsSweden becomes first country to meet UN targets for HIV epidemic
Sweden has reached the UNAIDS and WHO targets for the HIV epidemic, according to a study in Eurosurveillance by researchers at Karolinska Institutet and others. According to the researchers, Sweden is the first country in the world to achieve these targets. Source: Andreas Andersson Anders Sönnerborg Sweden ...
-
NewsFirst report of its kind describes HIV reservoir landscape in breast milk
In the first report of its kind, researchers have evaluated the HIV reservoir in the breast milk cells of two women living with HIV (WLWH) who had been on successful long-term treatment.
-
NewsPromising TB therapy safe for patients with HIV
A therapy showing promise to help control tuberculosis (TB) does not interfere with combined antiretroviral therapy (cART), according to new research.
-
NewsTwo-dose schedule could make HIV vaccines more effective
Researchers have found that the first dose primes the immune system, helping it to generate a strong response to the second dose, a week later.
-
NewsTriple antibody therapy shows promise for long-lasting HIV control
A cocktail of three broadly neutralizing antibodies (bNAb) successfully suppressed virus in people living with HIV, a new study shows. Some participants showed long-term control of the virus months after antibody levels declined to low or undetectable.
-
NewsAn antidiabetic helps the immune system recognize reservoirs of HIV
Metformin, a drug used to treat type 2 diabetes, could help deplete the viral reservoir and eliminate it entirely in people living with HIV who receive antiretroviral therapy, a new study reveals.
-
NewsFirst sustained remission of HIV infection following a bone marrow transplant in the absence of protective mutation
A total of seven individuals worldwide (two patients in Berlin and patients in London, Düsseldorf, New York, City of Hope and Geneva) are considered likely to have been cured or to be in long-term remission of HIV infection after receiving a bone marrow transplant to treat blood cancer. ...
-
NewsChristian Gaebler receives ERC Starting Grant to study HIV patients living without medication
Prof. Christian Gaebler aims to develop treatments that cure HIV infection in patients or prompt the immune system to keep the virus in check in the long term, and has won funding to study patients who are already living without medication.
-
NewsResistance found in parasite infecting cutaneous leishmaniasis patient
Researchers who analyzed samples from a 46-year-old patient in Brazil found an amphotericin B-resistant strain of the parasite Leishmania amazonensis circulating for the first time in the country.
-
NewsNanoparticle platform offers step toward more effective Covid and HIV vaccines
Researchers have developed a nanoparticle platform that could make existing vaccines more effective, including those for influenza, COVID-19, and HIV.
-
NewsNew technique offers insights into the complexities of chronic Hepatitis B infection
A new technique called spatial transcriptomics is used to gain a deeper understanding of the interplay between chronic hepatitis B (CHB) infection and the immune system within the liver, paving the way for developing novel therapeutic strategies.
-
NewsStudy says new drug shows promise in clearing HIV from brain
An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new study.
-
NewsNew study determines incidence of and risk factors for hepatitis C virus reinfection among men with HIV
A new study provides new perspectives on transmission of hepatitis C virus (HCV), a virus that infects the liver and can be transmitted during injection of drugs, among men who have sex with men (MSM).
-
NewsExploratory analysis associates HIV drug abacavir with elevated cardiovascular disease risk in large global trial
Current or previous use of the antiretroviral drug (ARV) abacavir was associated with an elevated risk of major adverse cardiovascular events (MACE) in people with HIV, according to an exploratory analysis from a large international clinical trial primarily funded by the National Institutes of Health (NIH). There ...
